Indolyl nicotinic hydrazides and their neurological studies

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Indole derivatives are a significant class of heterocyclic compounds with diverse biological activities.
• Central Nervous System (CNS) disorders, including Parkinson's disease, represent a major global health challenge.
• Monoamine oxidase (MAO) inhibitors are crucial therapeutic agents for neurological conditions.

Purpose of the Study:

• To synthesize a novel series of 2-substituted indole derivatives.
• To evaluate the synthesized compounds for potential Central Nervous System (CNS) activity.
• To assess the anti-Parkinsonian and monoamine oxidase (MAO) inhibitory properties of the novel compounds.

Main Methods:

• Synthesis involved cyclization reactions of 2-substituted-indole-3-carboxaldehyde with nicotinic acid hydrazide.
• Key intermediates underwent catalytic reduction, reactions with thioglycolic acid, and cyclization with chloroacetyl chloride.
• Further modifications included reactions with substituted arylaldehydes and 2-chloropropionic acid, and diazotization.

Main Results:

• A series of novel indole derivatives (compounds III-IX) were successfully synthesized.
• The synthesized compounds were evaluated for their pharmacological activities.
• Preliminary results indicate potential for CNS, anti-Parkinsonian, and MAO inhibitory effects.

Conclusions:

• The study successfully developed a new synthetic route to diverse indole derivatives.
• The synthesized compounds show promise as potential therapeutic agents for CNS disorders.
• Further research is warranted to optimize and develop these compounds for clinical application.